Cutaneous Amyloidosis | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: Education

Scientific literature and patient education texts

Back to Education / Patient Education

Cutaneous Amyloidosis

key information

source: The Australasian College of Dermatologist

year: N/A

summary/abstract:

Amyloidosis is a group of conditions characterised by the deposition of amyloid protein in organ systems. About 18 different types of amyloid protein have been identified.
 

There are three main types of amyloidosis:

 •  Primary cutaneous amyloidosis is a condition where amyloid protein is deposited in apparently normal skin without associated deposits in internal organs.
 •  Primary systemic amyloid may develop as a consequence of an underlying abnormality of the plasma cells in the bone marrow or plasma cell cancer (multiple myeloma). In systemic amyloidosis, the skin is involved along with many other organ systems such as the heart, the nerves, the kidneys and the liver.
 •  Secondary systemic amyloidosis is seen as a complication of a severe chronic infection such as tuberculosis, or a chronic inflammatory disorder such as rheumatoid arthritis or inflammatory bowel disease. Long-term haemodialysis may be associated with systemic amyloid. In rare cases, it can also be associated with inherited disorders.
 
read more

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close